User profiles for Jeremy Chambers
Jeremy W. ChambersAssociate Professor of Environmental Health Sciences, Florida International University Verified email at fiu.edu Cited by 1455 |
Glutamine metabolism is essential for human cytomegalovirus infection
JW Chambers, TG Maguire, JC Alwine - Journal of virology, 2010 - Am Soc Microbiol
Human fibroblasts infected with human cytomegalovirus (HCMV) were more viable than
uninfected cells during glucose starvation, suggesting that an alternate carbon source was used…
uninfected cells during glucose starvation, suggesting that an alternate carbon source was used…
[HTML][HTML] Mitochondrial c-Jun N-terminal kinase (JNK) signaling initiates physiological changes resulting in amplification of reactive oxygen species generation
JW Chambers, PV LoGrasso - Journal of Biological Chemistry, 2011 - ASBMB
The JNK signaling cascade is critical for cellular responses to a variety of environmental
and cellular stimuli. Although gene expression aspects of JNK signal transduction are well …
and cellular stimuli. Although gene expression aspects of JNK signal transduction are well …
Atmospheric oxygen inhibits growth and differentiation of marrow‐derived mouse mesenchymal stem cells via a p53‐dependent mechanism: implications for long …
Large scale expansion of human mesenchymal stem cells (MSCs) is routinely performed for
clinical therapy. In contrast, developing protocols for large scale expansion of primary …
clinical therapy. In contrast, developing protocols for large scale expansion of primary …
[HTML][HTML] Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats
JW Chambers, A Pachori, S Howard, S Iqbal… - Journal of Biological …, 2013 - ASBMB
To build upon recent findings that mitochondrial JNK signaling is inhibited by selectively
blocking the interaction between JNK and Sab, we utilized a cell-permeable peptide to …
blocking the interaction between JNK and Sab, we utilized a cell-permeable peptide to …
Small molecule c-jun-N-terminal kinase inhibitors protect dopaminergic neurons in a model of Parkinson's disease
JW Chambers, A Pachori, S Howard… - ACS chemical …, 2011 - ACS Publications
There are currently no drugs to treat neurodegeneration in Parkinson’s disease (PD), and
all existing medications only treat symptoms, lose efficacy over time, and produce untoward …
all existing medications only treat symptoms, lose efficacy over time, and produce untoward …
Phosphoregulation on mitochondria: Integration of cell and organelle responses
…, AE Suarez, JW Chambers - CNS neuroscience & …, 2019 - Wiley Online Library
Mitochondria are highly integrated organelles that are crucial to cell adaptation and mitigating
adverse physiology. Recent studies demonstrate that fundamental signal transduction …
adverse physiology. Recent studies demonstrate that fundamental signal transduction …
[HTML][HTML] Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo
JW Chambers, S Howard, PV LoGrasso - Journal of Biological Chemistry, 2013 - ASBMB
Because oxidative stress and mitochondrial dysfunction are well known contributors to
Parkinson disease (PD), we set out to investigate the role mitochondrial JNK plays in the etiology …
Parkinson disease (PD), we set out to investigate the role mitochondrial JNK plays in the etiology …
Novel and structurally diversified bacterial DNA gyrase inhibitors discovered through a fluorescence-based high-throughput screening assay
…, S Vasile, LH Smith, JW Chambers… - ACS Pharmacology & …, 2022 - ACS Publications
Bacterial DNA gyrase, a type IIA DNA topoisomerase that plays an essential role in bacterial
DNA replication and transcription, is a clinically validated target for discovering and …
DNA replication and transcription, is a clinically validated target for discovering and …
Analysis of chemotherapeutic drug delivery at the single cell level using 3D-MSI-TOF-SIMS
…, I Paudel, JW Chambers… - Journal of The …, 2016 - ACS Publications
In this work, we show the advantages of label-free, tridimensional mass spectrometry imaging
using dual beam analysis (25 keV Bi 3 + ) and depth profiling (20 keV with a distribution …
using dual beam analysis (25 keV Bi 3 + ) and depth profiling (20 keV with a distribution …
Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors
…, J Habel, JD Laughlin, J Chambers… - Journal of medicinal …, 2010 - ACS Publications
Given the significant body of data supporting an essential role for c-jun-N-terminal kinase (JNK)
in neurodegenerative disorders, we set out to develop highly selective JNK inhibitors …
in neurodegenerative disorders, we set out to develop highly selective JNK inhibitors …